Related references
Note: Only part of the references are listed.Epidemiology of the inherited cardiomyopathies
William J. McKenna et al.
NATURE REVIEWS CARDIOLOGY (2021)
Plasma microrna expression profile for reduced ejection fraction in dilated cardiomyopathy
Maria Calderon-Dominguez et al.
SCIENTIFIC REPORTS (2021)
MicroRNA-221 is a potential biomarker of myocardial hypertrophy and fibrosis in hypertrophic obstructive cardiomyopathy
Derong Huang et al.
BIOSCIENCE REPORTS (2020)
A microRNA Expression Profile as Non-Invasive Biomarker in a Large Arrhythmogenic Cardiomyopathy Cohort
Maria Bueno Marinas et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Circulating microRNAs as potential biomarkers for psychiatric and neurodegenerative disorders
M. M. J. van den Berg et al.
PROGRESS IN NEUROBIOLOGY (2020)
Peripheral microRNA panels to guide the diagnosis of familial cardiomyopathy
Thalia Belmonte et al.
TRANSLATIONAL RESEARCH (2020)
Relations between circulating and myocardial fibrosis-linked microRNAs with left ventricular reverse remodeling in dilated cardiomyopathy
Ewa Dziewiecka et al.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2020)
Characterisation of circulating microRNA-21 levels in patients with hypertrophic cardiomyopathy
A. Ya Gudkova et al.
TERAPEVTICHESKII ARKHIV (2020)
Cardiac magnetic resonance in hypertrophic and dilated cardiomyopathies
Silvia Pradella et al.
RADIOLOGIA MEDICA (2020)
Circulating microRNA as a Biomarker for Coronary Artery Disease
Ibrahim T. Fazmin et al.
BIOMOLECULES (2020)
Post-Mortem Cardiac Magnetic Resonance for the Diagnosis of Hypertrophic Cardiomyopathy
Giovanni Donato Aquaro et al.
DIAGNOSTICS (2020)
microRNAs as biomarkers in Pompe disease
Antonietta Tarallo et al.
GENETICS IN MEDICINE (2019)
Differential expression of circulating miRNAs as a novel tool to assess BAG3-associated familial dilated cardiomyopathy
Carlos Zaragoza et al.
BIOSCIENCE REPORTS (2019)
The stability and persistence of blood and semen mRNA and miRNA targets for body fluid identification in environmentally challenged and laundered samples
Carrie Mayes et al.
LEGAL MEDICINE (2019)
CLINICAL UPDATES Inherited cardiomyopathies
Chris Miles et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Dilated cardiomyopathy
Heinz-Peter Schultheiss et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
microRNA Detection in Blood, Urine, Semen, and Saliva Stains After Compromising Treatments
Tiffany R. Layne et al.
JOURNAL OF FORENSIC SCIENCES (2019)
Aberrant expression of TNRC6a and miR-21 during myocardial infarction
Liang Li et al.
3 BIOTECH (2019)
Expression Profile of microRNAs in Hypertrophic Cardiomyopathy and Effects of microRNA-20 in Inducing Cardiomyocyte Hypertrophy Through Regulating Gene MFN2
Dongdong Sun et al.
DNA AND CELL BIOLOGY (2019)
Circulating microRNAs in Fabry Disease
Ke Xiao et al.
SCIENTIFIC REPORTS (2019)
Applications of miRNAs in cardiac development, disease progression and regeneration
Jeremy Kah Sheng Pang et al.
STEM CELL RESEARCH & THERAPY (2019)
Cardiology: hypertrophic cardiomyopathy
John Firth
CLINICAL MEDICINE (2019)
Arrhythmogenic Cardiomyopathy in 2018-2019: ARVC/ALVC or Both?
Richard G. Bennett et al.
HEART LUNG AND CIRCULATION (2019)
LncRNA-MIAT regulates fibrosis in hypertrophic cardiomyopathy (HCM) by mediating the expression of miR-29a-3p
Jing Zhou et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Differences in microRNA-29 and Pro-fibrotic Gene Expression in Mouse and Human Hypertrophic Cardiomyopathy
Yamin Liu et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2019)
Circulating microRNAs in arrhythmogenic right ventricular cardiomyopathy with ventricular arrhythmia
Shinya Yamada et al.
EUROPACE (2018)
miR-139-5p inhibits isoproterenol-induced cardiac hypertrophy by targetting c-Jun
Su Ming et al.
BIOSCIENCE REPORTS (2018)
The arrhythmogenic cardiomyopathy-specific coding and non-coding transcriptome in human cardiac stromal cells
Johannes Rainer et al.
BMC GENOMICS (2018)
Serum Exosomal MiR-92b-5p as a Potential Biomarker for Acute Heart Failure Caused by Dilated Cardiomyopathy
Tao Wu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
The relationship between myocardial fibrosis and myocardial microRNAs in dilated cardiomyopathy: A link between mir-133a and cardiovascular events
Pawel Rubis et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
Plasma microRNAs as biomarkers for Lamin A/C-related dilated cardiomyopathy
Rocio Toro et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2018)
MiR-1-3p that correlates with left ventricular function of HCM can serve as a potential target and differentiate HCM from DCM
Mengmeng Li et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
A pilot study of circulating microRNAs as potential biomarkers of Fabry disease
Giuseppe Cammarata et al.
Oncotarget (2018)
Circulating microRNA signature for the diagnosis of childhood dilated cardiomyopathy
Meng Jiao et al.
SCIENTIFIC REPORTS (2018)
Blood-based microRNA profiling in patients with cardiac amyloidosis
Anselm A. Derda et al.
PLOS ONE (2018)
The Genetic Determination of the Differentiation Between Ischemic Dilated Cardiomyopathy and Idiopathic Dilated Cardiomyopathy
Serap Tutgun Onrat et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2018)
Genetics of hypertrophic cardiomyopathy: A review of current state
M. Sabater-Molina et al.
CLINICAL GENETICS (2018)
Metabolic Syndrome, Dyslipidemia and Regulation of Lipoprotein Metabolism
Jahangir Iqbal et al.
CURRENT DIABETES REVIEWS (2018)
Expression of Bcl-2 and microRNAs in cardiac tissues of patients with dilated cardiomyopathy
Yong Wang et al.
MOLECULAR MEDICINE REPORTS (2017)
Relations between circulating microRNAs (miR-21, miR-26, miR-29, miR-30 and miR-133a), extracellular matrix fibrosis and serum markers of fibrosis in dilated cardiomyopathy
Pawel Rubis et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Inhibition of miR-208b improves cardiac function in titin-based dilated cardiomyopathy
Qifeng Zhou et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Fibrosis and Fibrotic Gene Expression in Pediatric and Adult Patients With Idiopathic Dilated Cardiomyopathy
Kathleen C. Woulfe et al.
JOURNAL OF CARDIAC FAILURE (2017)
Arrhythmogenic Cardiomyopathy: the Guilty Party in Adipogenesis
Ilaria Stadiotti et al.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2017)
Cardiac myocyte miR-29 promotes pathological remodeling of the heart by activating Wnt signaling
Yassine Sassi et al.
NATURE COMMUNICATIONS (2017)
A unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks
Sathyamangla V. Naga Prasad et al.
PLOS ONE (2017)
MiR-320a as a Potential Novel Circulating Biomarker of Arrhythmogenic CardioMyopathy
Elena Sommariva et al.
SCIENTIFIC REPORTS (2017)
Mir-21 Promotes Cardiac Fibrosis After Myocardial Infarction Via Targeting Smad7
Jinxia Yuan et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Hypertrophic Cardiomyopathy Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy
Ali J. Marian et al.
CIRCULATION RESEARCH (2017)
Sudden cardiac death: focus on the genetics of channelopathies and cardiomyopathies
Simona Magi et al.
JOURNAL OF BIOMEDICAL SCIENCE (2017)
miR-21 enhances cardiac fibrotic remodeling and fibroblast proliferation via CADM1/STAT3 pathway
Wei Cao et al.
BMC CARDIOVASCULAR DISORDERS (2017)
Circulating microRNAs as novel biomarkers for dilated cardiomyopathy
Hua Wang et al.
CARDIOLOGY JOURNAL (2017)
Plasma microRNA profiling of children with idiopathic dilated cardiomyopathy
Mehmet Enes Coskun et al.
BIOMARKERS (2016)
Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases
Yigal M. Pinto et al.
EUROPEAN HEART JOURNAL (2016)
Endomyocardial miR-133a levels correlate with myocardial inflammation, improved left ventricular function, and clinical outcome in patients with inflammatory cardiomyopathy
Christian Besler et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
MicroRNA-29a-3p attenuates ET-1-induced hypertrophic responses in H9c2 cardiomyocytes
Man Li et al.
GENE (2016)
Genetic basis of dilated cardiomyopathy
Alexandra Perez-Serra et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
The Diagnosis and Evaluation of Dilated Cardiomyopathy
Alan G. Japp et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Current Concepts on Diagnosis and Prognosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia
Sandra L. Castanos Gutierrez et al.
JOURNAL OF THORACIC IMAGING (2016)
Effects of mir-21 on Cardiac Microvascular Endothelial Cells After Acute Myocardial Infarction in Rats: Role of Phosphatase and Tensin Homolog (PTEN)/Vascular Endothelial Growth Factor (VEGF) Signal Pathway
Feng Yang et al.
MEDICAL SCIENCE MONITOR (2016)
Profiling of differentially expressed microRNAs in arrhythmogenic right ventricular cardiomyopathy
Hongliang Zhang et al.
SCIENTIFIC REPORTS (2016)
Circulating miR-185 might be a novel biomarker for clinical outcome in patients with dilated cardiomyopathy
Miao Yu et al.
SCIENTIFIC REPORTS (2016)
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC)
Silvia G. Priori et al.
EUROPEAN HEART JOURNAL (2015)
Blood-based microRNA signatures differentiate various forms of cardiac hypertrophy
Anselm A. Derda et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
Circulating microRNA as a biomarker for recovery in pediatric dilated cardiomyopathy
Shelley D. Miyamoto et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2015)
Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy
Lu Fang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Application of microRNAs in diagnosis and treatment of cardiovascular disease
A. Wronska et al.
ACTA PHYSIOLOGICA (2015)
Arrhythmogenic cardiomyopathy: a disease of intercalated discs
Martina Calore et al.
CELL AND TISSUE RESEARCH (2015)
Relation of Reduced Expression of MiR-150 in Platelets to Atrial Fibrillation in Patients With Chronic Systolic Heart Failure
Yaron Goren et al.
AMERICAN JOURNAL OF CARDIOLOGY (2014)
Inherited Cardiomyopathies
Jeffrey A. Towbin
CIRCULATION JOURNAL (2014)
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)
Perry M. Elliott et al.
EUROPEAN HEART JOURNAL (2014)
Therapeutic silencing of miR-652 restores heart function and attenuates adverse remodeling in a setting of established pathological hypertrophy
Bianca C. Bernardo et al.
FASEB JOURNAL (2014)
MiR-451 is decreased in hypertrophic cardiomyopathy and regulates autophagy by targeting TSC1
Lei Song et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2014)
Circulating miR-29a, Among Other Up-Regulated MicroRNAs, Is the Only Biomarker for Both Hypertrophy and Fibrosis in Patients With Hypertrophic Cardiomyopathy
Roberta Roncarati et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
MicroRNA-21 regulation of the progression of viral myocarditis to dilated cardiomyopathy
Hong-Fei Xu et al.
MOLECULAR MEDICINE REPORTS (2014)
miR-29b as a Therapeutic Agent for Angiotensin II-induced Cardiac Fibrosis by Targeting TGF-β/Smad3 signaling
Yang Zhang et al.
MOLECULAR THERAPY (2014)
Arrhythmogenic ventricular cardiomyopathy: A paradigm shift from right to biventricular disease
Ardan M. Saguner et al.
WORLD JOURNAL OF CARDIOLOGY (2014)
Association of the miR-146a, miR-149, miR-196a2, and miR-499 Polymorphisms With Ischemic Stroke and Silent Brain Infarction Risk
Young Joo Jeon et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
MicroRNA-22 Downregulation by Atorvastatin in a Mouse Model of Cardiac Hypertrophy: a new Mechanism for Antihypertrophic Intervention
Yingfeng Tu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2013)
MicroRNA29 A Mechanistic Contributor and Potential Biomarker in Atrial Fibrillation
Kristin Dawson et al.
CIRCULATION (2013)
Choline Protects Against Cardiac Hypertrophy Induced by Increased After-load
Yilei Zhao et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2013)
miRNA-548c: A specific signature in circulating PBMCs from dilated cardiomyopathy patients
Manveen K. Gupta et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2013)
Circulating miRNA as novel markers for diastolic dysfunction
Nandini Nair et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2013)
A Deep Sequencing Approach to Uncover the miRNOME in the Human Heart
Stefanos Leptidis et al.
PLOS ONE (2013)
MicroRNA Dysregulation in Diabetic Ischemic Heart Failure Patients
Simona Greco et al.
DIABETES (2012)
A novel reciprocal loop between microRNA-21 and TGFβRIII is involved in cardiac fibrosis
Haihai Liang et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
Mutual antagonism between IP3RII and miRNA-133a regulates calcium signals and cardiac hypertrophy
Faye M. Drawnel et al.
JOURNAL OF CELL BIOLOGY (2012)
MiR-221 promotes cardiac hypertrophy in vitro through the modulation of p27 expression
Changxin Wang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
A translational study of urine miRNAs in acute myocardial infarction
Yunhui Cheng et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2012)
The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury
Alison J. Kriegel et al.
PHYSIOLOGICAL GENOMICS (2012)
Inhibition of miR-29 by TGF-beta-Smad3 Signaling through Dual Mechanisms Promotes Transdifferentiation of Mouse Myoblasts into Myofibroblasts
Liang Zhou et al.
PLOS ONE (2012)
The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy
Ahmet Ucar et al.
NATURE COMMUNICATIONS (2012)
Profile of MicroRNAs Differentially Produced in Hearts from Patients with Hypertrophic Cardiomyopathy and Sarcomeric Mutations
Maria Palacin et al.
CLINICAL CHEMISTRY (2011)
microRNAs in hypertrophy and heart failure
Michael V. G. Latronico et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2011)
A Cellular MicroRNA, let-7i, Is a Novel Biomarker for Clinical Outcome in Patients With Dilated Cardiomyopathy
Mamoru Satoh et al.
JOURNAL OF CARDIAC FAILURE (2011)
NFATc4 is negatively regulated in miR-133a-mediated cardiomyocyte hypertrophic repression
Qi Li et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Proposed Modification of the Task Force Criteria
Frank I. Marcus et al.
CIRCULATION (2010)
MicroRNAs 1, 133, and 206: Critical factors of skeletal and cardiac muscle development, function, and disease
W. H. Davin Townley-Tilson et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)
Dilated cardiomyopathy
John Lynn Jefferies et al.
LANCET (2010)
Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines
Hongli Shan et al.
CARDIOVASCULAR RESEARCH (2009)
MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue
Sashwati Roy et al.
CARDIOVASCULAR RESEARCH (2009)
miR-133 and miR-30 Regulate Connective Tissue Growth Factor Implications for a Role of MicroRNAs in Myocardial Matrix Remodeling
Rudy F. Duisters et al.
CIRCULATION RESEARCH (2009)
Oncomirs: From Tumor Biology to Molecularly Targeted Anticancer Strategies
Simone Mocellin et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2009)
miRNA expression in the failing human heart: Functional correlates
Carmen Sucharov et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2008)
Left-Dominant Arrhythmogenic Cardiomyopathy
Srijita Sen-Chowdhry et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Thomas Thum et al.
NATURE (2008)
MicroRNA and cardiac pathologies
Michael V. G. Latronico et al.
PHYSIOLOGICAL GENOMICS (2008)
MicroRNA-133 controls cardiac hypertrophy
Alessandra Care et al.
NATURE MEDICINE (2007)
Cardiomyopathy, familial dilated
Matthew R. G. Taylor et al.
ORPHANET JOURNAL OF RARE DISEASES (2006)
Myogenic factors that regulate expression of muscle-specific, microRNAs
Prakash K. Rao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Share Paper
